Related Experiment Video
Updated: Jun 5, 2026

An Integrated Workflow of Identification and Quantification on FDR Control-Based Untargeted Metabolome
Published on: September 20, 2022
Untargeted metabolite discovery in kinetic data from multi-dose intervention studies.
Sonja Peters1, Hans-Gerd Janssen, Gabriel Vivó-Truyols
1Unilever Research and Development, Advanced Measurement and Data Modelling, Vlaardingen, The Netherlands. sonja.peters@unilever.com
A novel biomarker discovery strategy uses multi-dose kinetic metabolomics to identify metabolites with consistent trends across doses and time. This method efficiently reduces large datasets, highlighting relevant compounds for further study.
Area of Science:
- Metabolomics
- Biomarker Discovery
- Analytical Chemistry
Background:
- Metabolomics studies generate vast datasets, necessitating efficient methods for identifying relevant biomarkers.
- Distinguishing true biological signals from noise is challenging in complex biological samples.
Purpose of the Study:
- To present a new strategy for biomarker discovery using multi-dose kinetic metabolomics data.
- To develop a method for reducing large metabolomics datasets to a manageable list of relevant compounds.
Main Methods:
- Utilized gas chromatography-mass spectrometry (GC-MS) data in full scan mode.
- Analyzed time and dosage trends of compounds using principal component analysis.
- Focused on compounds exhibiting consistent trends across all doses and time points.
Main Results:
- Successfully reduced over 25,000 features to less than 250 in a gut fermentation study.
- Identified relevant metabolites by filtering for compounds with expected smooth time profiles across doses.
- Demonstrated the method's ability to flag relevant metabolites even with unique trends.
Conclusions:
- The proposed strategy effectively reduces large metabolomics datasets for biomarker discovery.
- This approach streamlines the identification of biologically meaningful metabolites.
- The method offers a significant reduction in the manual examination of complex data.
More Related Videos
11:00Untargeted Metabolomics from Biological Sources Using Ultraperformance Liquid Chromatography-High Resolution Mass Spectrometry (UPLC-HRMS)
Published on: May 20, 2013
07:34Large Scale Non-targeted Metabolomic Profiling of Serum by Ultra Performance Liquid Chromatography-Mass Spectrometry (UPLC-MS)
Published on: March 14, 2013
Related Concept Videos
Measurement of Bioavailability: Pharmacokinetic Methods
Model-Independent Approaches for Pharmacokinetic Data: Noncompartmental Analysis
One important characteristic of noncompartmental analyses is that drug exposure increases proportionally with increasing doses. This relationship...
Bioavailability Study Design: Single Versus Multiple Dose Studies
Analysis Methods of Pharmacokinetic Data: Model and Model-Independent Approaches
The model approach uses mathematical models to describe changes in drug concentration over time. Pharmacokinetic models help characterize drug behavior in patients, predict drug concentration in the body fluids, calculate optimum dosage regimens, and evaluate the risk of toxicity. However, ensuring that the model fits the experimental data accurately...
Measurement of Bioavailability: Pharmacodynamic Methods
Dosage Regimens: Partial Pharmacokinetic Parameters